11/21
01:14 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Neutral
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
11/21
08:08 am
zntl
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
Low
Report
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]
11/15
02:07 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
Low
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Guggenheim from $12.00 to $8.00. They now have a "buy" rating on the stock.
11/15
08:03 am
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
High
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/13
08:00 am
zntl
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
Low
Report
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
11/1
07:04 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/15
08:47 am
zntl
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News [Yahoo! Finance]
Low
Report
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News [Yahoo! Finance]
9/17
12:48 pm
zntl
FDA lifts partial clinical hold on Zentalis Pharma's cancer WEE1 inhibitor [Yahoo! Finance]
Low
Report
FDA lifts partial clinical hold on Zentalis Pharma's cancer WEE1 inhibitor [Yahoo! Finance]
9/16
09:38 pm
zntl
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
High
Report
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
9/16
02:04 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $20.00 price target on the stock.
Medium
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $20.00 price target on the stock.
9/16
07:00 am
zntl
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
Medium
Report
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
9/9
07:00 am
zntl
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
Low
Report
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
9/3
04:40 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/26
02:00 pm
zntl
Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why [Yahoo! Finance]
Low
Report
Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why [Yahoo! Finance]